The murine gene p27(Kip 1) is haplo-insufficient for tumour suppression

Nature

Volumn 396, Issue 6707, 1998, Pages 177-180

  Fero, Matthew L ^a   Randel, Erin ^a   Gurley, Kay E ^a   Roberts, James M ^a,b   Kemp, Christopher J ^a  

^a USA   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN P27; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CDKN1B PROTEIN, MOUSE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; ETHYLNITROSOUREA; MICROTUBULE ASSOCIATED PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; DISEASE PREDISPOSITION; ENZYME INHIBITION; GAMMA IRRADIATION; GENE MAPPING; HISTOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; ANIMAL; C57BL MOUSE; EXPERIMENTAL NEOPLASM; FEMALE; GAMMA RADIATION; GENETICS; HAPLOTYPE; HETEROZYGOTE; MALE;

ANIMALS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ETHYLNITROSOUREA; FEMALE; GAMMA RAYS; GENES, TUMOR SUPPRESSOR; HAPLOTYPES; HETEROZYGOTE; MALE; MICE; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASMS, EXPERIMENTAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0032511848     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/24179     Document Type: Article

References (30)

1. Polyak, K. et al. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22 (1994).
2. Nourse, J. et al. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372, 570-573 (1994).
3. Kato, J. Y., Matsuoka, M., Polyak, K., Massague, J. & Sherr, C. J. Cyclin AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79, 487-496 (1994).
4. Coats, S., Flanagan, W. M., Nourse, J. & Roberts, J. M. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272, 877-880 (1996).
5. Fero, M. L. et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27kip1-deficient mice. Cell 85, 733-744 (1996).
6. Porter, P. L. et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med. 3, 222-225 (1997).
7. Loda, M. et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med. 3, 231-234 (1997).
8. Esposito, V. et al. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res. 57, 3381-3385 (1997).
9. Yang, R. M. et al. Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J. Urol. 159, 941-945 (1998).
10. Yasui, W., Kudo, Y., Semba, S., Yokozaki, H. & Tahara, E. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn. J. Cancer Res. 88, 625-629 (1997).
11. Pietenpol, J. A. et al. Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res. 55, 1206-1210 (1995).
12. Kawamata, N. et al. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res. 55, 2266-2269 (1995).
13. Morosetti, R. et al. Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood 86, 1924-1930 (1995).
14. Spirin, K. S. et al. p27/Kip1 mutation found in breast cancer. Cancer Res. 56, 2400-2404 (1996).
15. Knudson, A. G. Jr Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA 68, 820-823 (1971).
16. Dryja, T. P. et al. Homozygosity of chromosome 13 in retinoblastoma. N. Engl. J. Med. 310, 550-553 (1984).
17. Baker, S. J. et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244, 217-221 (1989).
18. Kamb, A. et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436-440 (1994).
19. Harvey, M. et al. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Genet. 5, 225-229 (1993).
20. Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37 (1996).
21. Hu, N. et al. Heterozygous Rb-1/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9, 1021-1027 (1994).
22. Jacks, T. et al. Effects of an Rb mutation in the mouse. Nature 359, 295-300 (1992).
23. Takeuchi, S. et al. Frequency loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12. Cancer Res. 56, 738-740 (1996).
24. Stegmaier, K. et al. Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia. Cancer Res. 56, 1413-1417 (1996).
25. Hayette, S. et al. Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias. Leukemia 11, 1696-1699 (1997).
26. Tang, B. et al. Transforming growth factor B1 is a new form of tumor suppressor with true haploid insufficiency. Nature Med. 4, 802-807 (1998).
27. Bouffler, S. D., Kemp, C. J., Balmain, A. & Cox, R. Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice. Cancer Res. 55, 3883-3889 (1995).
28. Gottlieb, E. et al. Transgenic mouse model for studying the transcriptional activity of the p53 protein: age-and tissue dependent changes in radiation-induced activation during embryogenesis. EMBO J. 16, 1381-1390 (1997).
29. Clarke, A. R. et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849-852 (1993).
30. Polyak, K. et al. Cloning of p27Kip1, a cydin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66 (1994).